title: In vitro identification and functional characterization of glial precursor cells in human gliomas.
abstract: Human gliomas including astrocytomas and oligodendrogliomas are defined as being composed of neoplastic astrocytes and oligodendrocytes respectively. Here, on the basis of in vitro functional assays, we show that gliomas contain a mixture of glial progenitor cells and their progeny. We have set up explant cultures from pilocytic astrocytomas, glioblastomas and oligodendrogliomas and studied antigens that characterize glial lineage, from the precursor cells (glial restricted precursors and oligodendrocyte-type2-astrocyte/oligodendrocyte precursor cells expressing the A2B5 ganglioside) to the differentiated cells (oligodendrocyte and type-1 and type-2 astrocytes). All tumoral explants contain A2B5+ cells and can generate migrating cells with distinctive functional properties according to glioma subtypes. In pilocytic astrocytomas, very few migrating cells are dividing and can differentiate in type-2 astrocytes or towards the oligodendrocyte lineage. In glioblastomas, most migrating cells are dividing, express A2B5 or glial fibrillary acid protein (GFAP) and can generate oligodendrocytes and type-1 and type-2 astrocytes in appropriate medium. Oligodendroglioma explants are made by actively dividing glial precursor cells expressing A2B5 or PSA-NCAM. Only few cells can migrate and differentiation towards oligodendrocyte lineage does not occur. Isolated A2B5+ cells from both glioblastomas and oligodendrogliomas showed similar genetic alterations as the whole tumour. Therefore, pilocytic astrocytomas contain slowly dividing oligodendrocyte-type2-astrocyte/oligodendrocyte precursor cells in keeping with their benign behaviour whereas both glioblastomas and oligodendrogliomas contain neoplastic glial restricted precursor cells. In oligodendrogliomas, these cells are trapped in undifferentiated and proliferating state. The precursor cells properties present in gliomas give new insight into their histogenesis and open up new avenues for research in the field of gliomagenesis.
authors.affiliation: Laboratoire de Biopathologie de l'Adhésion et de la Signalization, EA3281, IPHM, Faculté de Médecine Timone, Marseilles, France.
authors.forename: C
authors.initials: C
authors.lastname: Colin
authors.forename: N
authors.initials: N
authors.lastname: Baeza
authors.forename: S
authors.initials: S
authors.lastname: Tong
authors.forename: C
authors.initials: C
authors.lastname: Bouvier
authors.forename: B
authors.initials: B
authors.lastname: Quilichini
authors.forename: P
authors.initials: P
authors.lastname: Durbec
authors.forename: D
authors.initials: D
authors.lastname: Figarella-Branger
mesh_terms: D000328:Adult; D001932:Brain Neoplasms / Q000235:genetics / Q000503:physiopathology*; D002454:Cell Differentiation; D019070:Cell Lineage; D002465:Cell Movement; D002648:Child; D002675:Child, Preschool; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D005910:Glioma / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D008875:Middle Aged; D009457:Neuroglia / Q000166:cytology*; D013234:Stem Cells / Q000166:cytology*
chemical_list: D005904:Glial Fibrillary Acidic Protein